BRAIN Biotech AG (ETR:BNN)
Germany
· Delayed Price · Currency is EUR 2.340
-0.020 (-0.85%)
Mar 6, 2026, 5:35 PM CET
BRAIN Biotech AG Revenue
BRAIN Biotech AG had revenue of 12.05M EUR in the quarter ending December 31, 2025, a decrease of -9.10%. This brings the company's revenue in the last twelve months to 49.01M, down -12.20% year-over-year. In the fiscal year ending September 30, 2025, BRAIN Biotech AG had annual revenue of 50.22M, down -9.52%.
Revenue (ttm)
49.01M
Revenue Growth
-12.20%
P/S Ratio
1.04
Revenue / Employee
167.84K
Employees
292
Market Cap
51.12M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 50.22M | -5.28M | -9.52% |
| Sep 30, 2024 | 55.50M | -725.00K | -1.29% |
| Sep 30, 2023 | 56.23M | 5.93M | 11.79% |
| Sep 30, 2022 | 50.30M | 11.07M | 28.23% |
| Sep 30, 2021 | 39.22M | 158.00K | 0.40% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| H2APEX Group SCA | 11.06M |
| Nabaltec AG | 202.27M |
| Masterflex SE | 101.09M |
| H&R GmbH & Co. KGaA | 1.30B |
| Uzin Utz SE | 486.35M |
| LANXESS Aktiengesellschaft | 5.89B |
| AlzChem Group AG | 575.05M |
| Verbio SE | 1.73B |